Investor Overview
 |
KindredBio is focused on bringing breakthrough human products and innovative new technologies to veterinary medicine to address unmet clinical needs and provide benefits to animal co...
Stock Information
NASDAQ CM$15.15NEWS
Kindred Biosciences Announces Second Quarter 2018 Financial Results
August 9, 2018
SAN FRANCISCO, Aug. 9, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences to Announce Second Quarter 2018 Financial Results
July 16, 2018
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...
Kindred Biosciences Announces Commercial Availability of Mirataz® (mirtazapine transdermal ointment) to Veterinarians in the United States
July 9, 2018
SAN FRANCISCO, July 9, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...